HQL

abrdn Life Sciences Investors
HQL

Overview Fund Trends Analyst Outlook Journalist POV

45 hedge funds and large institutions have $40.7M invested in abrdn Life Sciences Investors in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$764K
2
+$488K
3
+$404K
4
NIM
Needham Investment Management
New York
+$401K
5
Bank of Nova Scotia
Bank of Nova Scotia
Ontario, Canada
+$315K

Top Sellers

1
-$875K
2
-$688K
3
-$532K
4
Morgan Stanley
Morgan Stanley
New York
-$289K
5
UBS Group
UBS Group
Switzerland
-$285K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$224K
27
$219K
28
$191K
29
$176K
30
$175K
31
$108K
32
$59K
33
$43K
34
$32K
35
$30K
36
$23K
37
$19K
38
$18K
39
$13K
40
$10K
41
$1K
42
$1K
43
$1K
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2